In comparison to the HER2- tumors, HER2+ tumors presented with more aggressive features, i.e., with a larger tumor size (p = 0.034), more advanced nodal status (p = 0.015) and higher grade (p < 0.001). The gene discussed is ERBB2; the disease is neoplasm.